# Clinical Trial for 'Shen Qu Xiao Shi' Oral Liquid in the Treatments of Children's Functional Dyspepsia

> **NCT05030116** · PHASE4 · COMPLETED · sponsor: **Ruijin Hospital** · enrollment: 356 (actual)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Shenqu Xiaoshi oral liquid
- **DRUG:** Domperidone suspension

## Key facts

- **NCT ID:** NCT05030116
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-26
- **Primary completion:** 2020-05-10
- **Final completion:** 2020-05-23
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05030116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05030116, "Clinical Trial for 'Shen Qu Xiao Shi' Oral Liquid in the Treatments of Children's Functional Dyspepsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05030116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*